Stimulants are psychotropic drugs that produce excitation of the central nervous system (CNS). Stimulants have been used in the management of children and adolescents since the 1930s when Dr Charles Bradley first used Benzedrine to treat children with behavioral disturbances (Bradley, 1937).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abikoff, H., Hechtman, L., Klein, R. G., Gallagher, R., Fleiss, K., Etcovitch, J., et al. (2004). Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child & Adolescent Psychiatry, 43, 820-829.
Adesman, A. R. (2002). New medications for treatment of children with Attention-Deficit/Hyperactivity Disorder: Review and commentary. Pediatric Annals, 31, 514-523.
Alto, J. L., & Frankenberger, W. (1994). Effects of methylphenidate on academic achievement from first to second grade. International Journal of Disability, Development and Education, 42, 259-273.
Aman, M. G., Buican, B., & Arnold, L. E. (2003). Methylphenidate treatment in children with borderline IQ and mental retardation: Analysis of three aggregated studies. Journal of Child and Adolescent Psychopharmacology, 13, 29-40.
Aman, M. G., Kern, R. A., McGhee, D. E., & Arnold, L. E. (1993). Fenfluramine and methylphenidate in children with mental retardation and Attention Deficit Hyperactivity Disorder: Laboratory effects. Journal of Autism & Developmental Disorder, 23, 491-506.
Aman, M. G., Kern, R. A., Osborne, P., Tumuluru, R., Rojahn, J., & Del Medico, V. (1997). Fenfluramine and methylphenidate in children with mental retardation and borderline IQ: Clinical effects. American Journal of Mental Retardation, 101, 521-534.
Aman, M. G., Marks, R. E., Turbott, S. H., Wilsher, C. P., & Merry, S. N. (1991). Clinical effects of methylphenidate and thioridazine in intellectually subaverage children. Journal of the American Academy of Child & Adolescent Psychiatry, 30, 246-256.
Aman, M., & Werry, J. S. (1982). Methylphenidate and diazepam in severe reading retardation. Journal of the American Academy of Child Psychiatry, 2, 31-37.
American Academy of Child & Adolescent Psychiatry. (2002). Practice parameters for the use of stimulant medication. Journal of the American Academy of Child & Adolescent Psychiatry, 41, 1146-1147.
American Psychiatric Association. (1980). Diagnostic and Statistical Manual of Mental Disorders (3rd ed.). Washington, DC: Author.
American Psychiatric Association. (1987). Diagnostic and statistical manual for mental disorders (3rd rev. ed.). Washington, DC: Author.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
American Psychiatric Association. (2000). Diagnostic and statistical manual for mental disorders (4th ed., text revision). Washington, DC: Author.
Amery, B., Minichiello, M. D., & Brown, G. L. (1984). Aggression in hyperactive boys: response to D-amphetamine. Journal of the American Academy of Child & Adolescent Psychiatry, 23, 291-294.
Anderson, V., & Taylor, H. G. (1999). Meningitis in childhood: Neuropsychological complications. In K. O. Yeates, M. D. Ris, & H. G. Taylor (Eds.), Pediatric neuropsychology: Research, theory and practice (pp. 117-148). New York: Guilford Press.
Angold, A., & Costello, E. J. (1997). Stimulant medication: A general population perspective [Abstract]. New Clinical Drug Evaluation Unit (NCDEU) Abstracts of the 37th Annual Meeting, May 27-30.
Angold, A., Erkanli, A., Egger, H. L., & Costello, E. J. (2000). Stimulant treatment for children: A community perspective. Journal of the American Academy of Child & Adolescent Psychiatry, 39, 975-984.
Arcia, E., Fernandez, M. C., & Jaquez, M. (2004). Latina mothers’stances on stimulant medication: Complexity, conflict, and compromise. Journal of Developmental & Behavioral Pediatrics, 25, 311-317.
Arnold, L. (2000). Methylphenidate vs. amphetamine: Comparative review. Journal of Attention Disorders, 3, 200-211.
Atkins, M. S., & Pelham, W. E. (1991). School-based assessment of Attention Deficit Hyperactivity Disorder. Journal of Learning Disabilities, 24, 197-204.
Ballinger, C. T., Varley, C. K., & Nolen, P. A. (1984). Effects of methylphenidate on reading in children with ADD. American Journal of Psychiatry, 141, 1590-1593.
Barkley, R. A. (1990). Attention deficit Hyperactivity Disorder: A handbook for diagnosis and treatment. New York: Guilford Press.
Barkley, R. A. (1995). Taking charge of ADHD: The complete, authoritative guide for parents. New York: Guilford Press.
Barkley, R. A. (1997). ADHD and the nature of self-control. New York: Guilford Press.
Barkley, R. A. (2005). Taking charge of ADHD: The complete, authoritative guide for parents (3rd ed.). New York: Guilford Press.
Barkley, R. A., & Cunningham, C. E. (1978). Do stimulant drugs improve academic performance of hyperkinetic children? Clinical Pediatrics, 17, 85-92.
Barkley, R. A., DuPaul, G. J., & Costello, A. (1993). Stimulants. In J. S. Werry, & M. G. Aman (Eds.), Practitioners guide to psychoactive drugs for children and adolescents (pp. 205-237). New York: Plenum.
Barkley, R. A., DuPaul, G. J., & McMurray, M. B. (1991). Attention Deficit Disorder with and without hyperactivity: Clinical response to three dose levels of methylphenidate. Pediatrics, 87, 519-531.
Barkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2003). Does the treatment of Attention-Deficit/Hyperactivity Disorder with stimulants contribute to drug use/abuse? A 13-year prospective study. Pediatrics, 111, 97-109.
Barkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2004). Young adult follow-up of hyperactive children: Antisocial activities and drug use. Journal of Child Psychology & Psychiatry, 45, 195-211.
Barkley, R. A., McMurray, M. B., Edelbrock, C. S., & Robbins, K. (1989). The response of aggressive and nonaggressive ADHD children to two doses of methylphenidate. Journal of the American Academy of Child & Adolescent Psychiatry, 28, 873-881.
Barkley, R. A., McMurray, M. B., Edelbrock, C. S., & Robbins, K. (1990). Side effects of methylphenidate in children with Attention Deficit Hyperactivity Disorder: A systematic, placebo-controlled evaluation. Pediatrics, 86, 184-192.
Barnett, R., Maruff, P., Vance, A., Luk, E. S. L., Costin, J., Wood, C., et al. (2001). Abnormal executive function in Attention Deficit Hyperactivity Disorder: The effect of stimulant medication and age on spatial working memory. Psychological Medicine, 31, 1107-1115.
Bedard, A. C., Martinussen, R., Ickowicz, A., & Tannock, R. (2004). Methylphenidate improves visual-spatial memory in children with Attention-Deficit/Hyperactivity Disorder. Child & Adolescent Social Work Journal, 21, 260-268.
Benedetto-Nasho, E., & Tannock, R. (1999). Math computation performance and error patterns of children with Attention Deficit Hyperactivity Disorder. Journal of Attention Disorders, 3, 121-134.
Ben Pazi, H., Gross-Tsur, V., Bergman, H., & Shalev, R. S. (2003). Abnormal rhythmic motor response in children with attention-deficit-hyperactivity disorder. Developmental Medicine & Child Neurology, 45, 743-745.
Bennett, F. C., Brown, R. T., Craver, J., & Anderson, D. (1999). Stimulant medication for the child with attention-deficit/hyperactivity disorder. Pediatric Clinics of North America, 46, 929-943.
Biederman, J., Faraone, S. V., & Lahey, K. (1992). Comorbidity of diagnosis in attention-deficit hyperactivity disorder. Child & Adolescent Psychiatric Clinics of North America, 1, 335-360.
Biederman, J., Newcorn, J., & Sprich, S. (1991). Comorbidity of Attention Deficit Hyperactivity Disorder with conduct, depressive, anxiety, and other disorders. American Journal of Psychiatry, 148, 564-577.
Biederman, J., Wilens, T., Mick, E., Spencer, T., & Faraone, S. V. (1999). Pharmacotherapy of Attention-Deficit/Hyperactivity Disorder reduces risk for substance use disorder. Pediatrics, 104, E20.
Blackman, J. A. (1999). Attention-Deficit/Hyperactivity Disorder in preschoolers: Does it exist and should we treat it? Pediatric Clinics of North America, 46, 1011-1025.
Blum, N. J., Mauk, J. E., McComas, J. J., & Mace, F. C. (1996). Separate and combined effects of methylphenidate and a behavioral intervention on disruptive behavior in children with mental retardation. Journal of Applied Behavior Analysis, 29, 305-319.
Bradley, C. (1937). The behaviour of children receiving benzedrine. American Journal of Psychiatry, 94, 577-585.
Brown, R. T., & Borden, K. A. (1989). Neuropsychological effects of stimulant medication on children’s learning and behavior. In C. R. Reynolds, & E. Fletcher-Janzen (Eds.), Handbook of clinical child neuropsychology (pp. 443-474). New York: Plenum Press.
Brown, R. T., & La Rosa, A. (2002). Recent developments in the pharmacotherapy of attention-deficit/hyperactivity disorder. Professional Psychology: Research and Practice, 33, 591-595.
Brown, R. T., & Sammons, M. T. (2003). Pediatric psychopharmacology: A review of new developments and recent research. Professional Psychology: Research & Practice, 33, 135-147.
Brown, R. T., & Sawyer, M. G. (1998). Medications for school-age children: Effects on learning and behavior. New York: Guilford Press.
Brown, R. T., & Sleator, E. K. (1979). Methylphenidate in hyperkinetic children: Differences in dose effects on impulsive behavior. Pediatrics, 64, 408-411.
Brown, R. T., Dingle, A. D., & Dreelin, E. (1997). Neuropsychological effects of stimulant medication on children’s learning and behavior. In C. R. Reynolds, & E. Fletcher-Janzen (Eds.), Handbook of clinical child neuropsychology (pp. 539-572). New York: Plenum Press.
Brown, R. T., Dingle, A., & Landau, S. (1994). Overview of psychopharmacology in children and adolescents. School Psychology Review, 9, 4-25.
Bowen, J., Fenton, T., & Rappaport, L. (1991). Stimulant medication and Attention-Deficit Hyperactivity Disorder: The child’s perspective. American Journal of Diseases of Children, 145, 291-295.
Brown, R. T., Mulhern, R., & Simonian, S. (2002). Diseases of the blood and blood forming organs. In T. Boll (Ed.), S. Bennett-Johnson, N. Perry, & R. Rozensky (Vol. 1 Eds.), Handbook of clinical health psychology: Volume 1. Medical disorders and behavioral applications (Vol. 3, pp. 101-141). Washington, DC: American Psychological Association.
Brown, R. T., Amler, R. W., Freeman, W. S., Perrin, J. M., Stein, M. T., Feldman, H. M., et al. (2005). Treatment of attention-deficit/hyperactivity disorder: Overview of the evidence. Pediatrics, 115, 749-757.
Broyd, S. J., Johnstone, S. J., Barry, R. J., Clarke, A. R., McCarthy, R., Selikowitz M., et al. (2005). The effect of methylphenidate on response inhibition and the event-related potential of children with Attention Deficit/Hyperactivity Disorder. International Journal of Psychophysiology, 58, 47-58.
Buhrmester, D., Camparo, L., Christensen, A., Gonzalez, L., & Hinshaw, S. (1992). Mothers and fathers interacting in dyads and triads of normal and hyperactive sons. Developmental Psychology, 28, 500-509.
Bukstein, O. G., & Kolko, D. J. (1998). Effects of methylphenidate on aggressive urban children with Attention Deficit Hyperactivity Disorder. Journal of Clinical & Child Psychology, 27, 340-351.
Burd, L. (1995). Children with Tourette Syndrome: A handbook for parents and teachers. Grand Forks, ND: Jessica Kingsley.
Butler, R. W., & Mulhern, R. K. (2005). Neurocognitive interventions for children and adolescents surviving cancer. Journal of Pediatric Psychology, 30, 65-78.
Butte, N., Treuth, M., Voigt, R., Llorente, A., & Heird, W. (1999). Stimulant medications decrease energy expenditure and physical activity in children with Attention Deficit/Hyperactivity Disorder. Journal of Pediatrics, 135, 203-207.
Calello, D., & Osterhoudt, K. (2004). Acute psychosis associated with therapeutic use of dextroamphetamine. Pediatrics, 113, 1466.
Canadian Pharmacists Association. (1999). Ritalin product monograph. In M. C. Gillis (Ed.), CPS Compendium of pharmaceuticals and specialties (34th ed.) (pp. 1573-1574). Ottawa: Author.
Carlson, C. L., Pelham, W. E., Milich, R., & Dixon, M. J. (1992). Single and combined effects of methylphenidate and behavior therapy on the classroom behavior, academic performance and self-evaluations of children with Attention Deficit-Hyperactivity Disorder. Journal of Abnormal Child Psychology, 20, 213-232.
Carlson, G. A., & Kelly, K. L. (2003). Stimulant rebound: How common is it and what does it mean? Journal of Child & Adolescent Psychopharmacology, 13, 137-142.
Casat, C. D., Gualtieri, C. T., Weller, E., Reader, M., Reiss, A., Weller, R. A., et al. (1996). Bupropion hydrochloride in Attention Deficit Disorder with hyperactivity. Journal of the American Academy of Child & Adolescent Psychiatry, 35, 1314-1321.
Casey, B. J., Castellanos, F. X., Giedd, J. N., Marsh, W. L., Hamburger, S. D., Schubert, A. B., et al. (1997). Implication of right frontostriatal circuitry in response inhibition and Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 36, 374-383.
Castellanos, F. X., Giedd, J. N., Elia, J., Marsh, W. L., Ritchie, G. F., Hamburger, S. D., et al. (1997). Controlled stimulant treatment of ADHD and comorbid Tourette’s Syndrome: Effects of stimulant and dose. Journal of the American Academy of Child & Adolescent Psychiatry, 36, 589-596.
Castellanos, F. X. (2002). Anatomic magnetic resonance imaging studies of Attention-Deficit/Hyperactivity Disorder. Dialogues in Clinical Neuroscience, 4, 444-448.
Castellanos, F. X., & Acosta, M. T. (2004). The neuroanatomy of Attention Deficit/Hyperactivity Disorder. Review of Neurology, 38, S131-S136.
Castellanos, F. X., Lee, P. P., Sharp, W., Jeffries, N. O., Greenstein, D. K., Clasen, L. S., et al. (2002). Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Medical Association, 288, 1740-1748.
Castellanos, F. X., Sharp, W. S., Gottesman, R. F., Greenstein, D. K., Giedd, J. N., & Rapoport, J. L. (2003). Anatomic brain abnormalities in monozygotic twins discordant for Attention Deficit Hyperactivity Disorder. American Journal of Psychiatry, 160, 1693-1696.
Chabot, R. J., Orgill, A. A., Crawford, G., Harris, M. J., & Serfontein, G. (1999). Behavioral and electrophysiologic predictors of treatment response to stimulants in children with attention disorders. Journal of Child Neurology, 14, 343-351.
Chacko, A., Pelham,W. E., Gnagy, E. M., Greiner, A., Vallano, G., Bukstein, O., et al. (2005). Stimulant medication effects in a summer treatment program among young children with Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 44, 249-257.
Charach, A., Ickowicz, A., & Schachar, R. (2004). Stimulant treatment over five years: Adherence, effectiveness, and adverse effects. Journal of the American Academy of Child & Adolescent Psychiatry, 43, 559-567.
Cherland, E., & Fitzpatrick, R. (1999). Psychotic side effects of psychostimulants: A 5-year review. Canadian Journal of Psychiatry, 44, 811-813.
Clarke, A. R., Barry, R. J., McCarthy, R., & Selikowitz, M. (1998). EEG analysis in attention-deficit/hyperactivity disorder: a comparative study of two subtypes. Psychiatry Research, 81, 19-29.
Clarke, A. R., Barry, R. J., McCarthy, R., & Selikowitz, M. (2002). EEG differences between good and poor responders to MPH and dexamphetamine in children with attention-deficit/hyperactivity disorder. Clinical Neurophysiology, 113, 194-205.
Claude-Bedard, A., Ickowicz, I., Logan, G. D., Hogg-Johnson, S., Schachar, R., & Tannock, R. (2003). Selective inhibition in children with attention-deficit hyperactivity disorder off and on stimulant medication. Journal of Abnormal Child Psychology, 31, 315-327.
Coie, J. K., & Dodge, K. A. (1998). Aggression and antisocial behavior. In E. M. Hetherington (Ed.), & W. Damon (Series Ed.), Handbook of child psychology: Vol. 3: Social, emotional, and personality development (pp. 779-862). New York: Wiley.
Connor, D. F. (2002). Preschool Attention Deficit Hyperactivity Disorder: A review of prevalence, diagnosis, neurobiology, and stimulant treatment. Journal of Developmental & Behavioral Pediatrics, 23, S1-S9.
Conners, C. K., Eisenberg, L., & Barcai, A. (1967). Effect of dextroamphetamine on children: Studies on subjects with learning disabilities and school behavior problems. Archives of General Psychiatry, 17, 478-485.
Connor, D. F., Glatt, S. J., Lopez, I. D., Jackson, D., & Melloni, R. H., Jr. (2002). Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD.Journal of the American Academy of Child & Adolescent Psychiatry, 41, 253-261.
Conners, C. K. (1997). Conners’ Rating Scales—Revised [technical manual]. Toronto: Multi-Health Systems.
Conners, C. K., Epstein, J. N., March, J. S., Angold, A., Wells, K. C., Klaric, J., et al. (2001). Multimodal treatment of ADHD in the MTA: An alternative outcome analysis. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 159-167.
Cooter, R. B., Jr. (1988). Effects of Ritalin on reading. Academic Therapy, 23, 461-469.
Coyle, J. T. (2000). Psychotropic drug use in very young children. Journal of the American Medical Association, 283, 1059-1060.
Cuffe, S. P., McKeown, R. E., Jackson, K. L., Addy, C. L., Abramson, R., & Garrison, C. Z. (2001). Prevalence of Attention-Deficit/Hyperactivity Disorder in a community sample of older adolescents. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 1037-1044.
Cunningham, C. E., & Siegel, L. S. (1987). The peer interactions of normal and attention deficit disordered boys during free play, cooperative task, and simulated classroom situations. Journal of Abnormal Child Psychology, 15, 247-268.
DeLong, R., Friedman, H., Friedman, N., Gustafson, K., & Oakes, J. (1992). Methylphenidate in neuropsychological sequelae of radiotherapy and chemotherapy of childhood brain tumors and leukemia. Journal of Child Neurology, 7, 462-463.
Denney, C., & Rapport, M. (2001). The cognitive pharmacology of stimulants in children with ADHD. In M. V. Solanto, A. F. T. Arnsten, & F. X. Castellanos (Eds.), Stimulant Drugs and ADHD: Basic and Clinical Neuroscience (pp. 283-302). New York: Oxford University Press.
De Quiros, G. B, Kinsbourne, M., Palmer, R. L., & Tocci Rufo, D. (1994). Attention Deficit Disorder in children: Three clinical variants. Journal of Developmental & Behavioral Pediatrics, 15, 311-319.
De Sonneville, L. M., Nijiokiktjien, C., & Bos, H. (1994). Methylphenidate and information processing. Part 1: Differentiation between responders and non responders; Part 2: Efficacy in responders. Journal of Clinical & Experimental Neuropsychology, 16, 877-897.
Di Michele, F., Prichep, L., John, E. R., & Chabot, R. J. (2005). The neurophysiology of Attention-Deficit/Hyperactivity Disorder. International Journal of Psychophysiology, 58, 81-93.
Disney, E. R., Elkins, I. J., McGue, M., & Iacono, W. G. (1999). Effects of ADHD, conduct disorder, and gender on substance use and abuse in adolescence. American Journal of Psychiatry, 156, 1515-1521.
Doherty, S., Frankenberger, W., Fuhrer, R., & Snider, V. (2000). Children’s self-reported effects of stimulant medication. International Journal of Disability Development & Education, 47, 39-54.
Dos Reis, S., Zito, J. M., Safer, D. J., Soeken, K. L., Mitchell, J. W., & Ellwood, L. (2003). Parental perceptions and satisfaction with stimulant medication for ADHD. Journal of Developmental & Behavioral Pediatrics, 24, 155-162.
Douglas, V. I. (1999). Cognitive control processes in Attention-Deficit/Hyperactivity Disorder. In H. C. Quay, & A. E. Hogan (Eds.), Handbook of disruptive behavior disorders (pp. 105-138). New York: Kluwer Academic/Plenum.
Douglas, V. I., & Peters, K. G. (1979). Toward a clearer definition of the attention deficit of hyperactive children. In E. A. Hale, & M. Lewis (Eds.), Attention and the development of cognitive skills (pp. 173-247). New York: Plenum.
DuPaul, G., & Rapport, M. D. (1993). Does methylphenidate normalize the classroom performance of children with Attention Deficit Disorder? Journal of the American Academy of Child & Adolescent Psychiatry, 32, 190-198.
DuPaul, G. J., & Stoner, G. (1999). Assessing ADHD in the schools [videotape]. New York: Guilford Press.
Douglas, V. I., Barr, R. G., Desilets, J., & Sherman, E. (1995). Do high doses of methylphenidate impair flexible thinking in Attention-Deficit Hyperactivity Disorder? Journal of the American Academy of Child & Adolescent Psychiatry, 34, 877-885.
DuPaul, G. J., Barkley, R. A., & McMurray, M. B. (1991). Therapeutic effects of medication on ADHD: Implications for school psychologists. School Psychology Review, 20, 203-219.
Efron, D., Jarman, F. C., & Barker, M. J. (1997). Methylphenidate versus dexamphetamine in children with Attention Deficit Hyperactivity Disorder: A double-blind crossover trial. Pediatrics, 100, E6.
Efron, D., Jarman, F. C., & Barker, M. J. (1998). Child and parent perceptions of stimulant medication treatment in Attention Deficit Hyperactivity Disorder. Journal of Pediatrics & Child Health, 34, 288-292.
Eisenberg, L., Lachman, R., Molling, P., Lockner, A., Mizelle, J., & Conners, C. (1961). A psychopharmacologic experiment in a training school for delinquent boys: methods, problems and findings. American Journal of Orthopsychiatry, 33, 431-447.
Elia, J., Borcherding, B., Rapoport, J., & Keysor, C. (1991). Methylphenidate and dextroamphetamine treatments of hyperactivity: Are there true non-responders? Psychiatry Research, 36, 141-155.
Elia, J., Welsh, P. A., Gullota, C. S., & Rapoport, J. L. (1993). Classroom academic performance: Improvement with both methylphenidate and dextroamphetamine in ADHD boys. Journal of Child Psychology & Psychiatry, 34, 785-804.
Elliott, S. N. (1988). Acceptability of behavioral treatments in educational settings. In J. C. Witt, S. W. Elliott, & F. M. Gresham (Eds.), Handbook of behavior therapy in education (pp. 121-150). New York: Plenum Press.
Ernst, M., Liebenauer, L. L., Tebeka, D., Jons, P. H., Eisenhofer, G., Murphy, D. L., et al. (1997). Selegiline in ADHD adults: plasma monoamines and monoamine metabolites. Neuropsychopharmacology, 16, 276-284.
Ernst, M., Zametkin, A. J., Matochik, J. A., Pascualvaca, D., Jons, P. H., & Cohen, R. M. (1999). High midbrain [18F] DOPA accumulation in children with Attention Deficit Hyperactivity Disorder. American Journal of Psychiatry, 156, 1209-1215.
Evans, S. W., Pelham, W. E., Smith, B. H. Bukstein, O., Gnagy, E. M., Greiner, A. R., et al. (2001). Dose-response effects of methylphenidate on ecologically valid measures of academic performance and classroom behavior in adolescents with ADHD. Experimental and Clinical Psychopharmacology, 9, 163-175.
Farley, S. E., Adams, J. S., Lutton, M. E., & Scoville, C. (2005). Clinical Inquiries: What are effective treatments for oppositional and defiant behaviors in preadolescents? Journal of Family Practice, 54, 164-165.
Faraone, S. V., Biederman, J., Spencer, T., Michelson, D., Adler, L., Reimherr, F., et al., (2005). Efficacy of atomoxetine in adult Attention-Deficit/Hyperactivity Disorder: A drug-placebo response curve analysis. Behavioral & Brain Functions, 1, 16.
Feldman, H., Crumrine, P., Handen, B. L., Alvin, R., & Teodori, J. (1989). Methylphenidate in children with seizures and Attention-Deficit Disorder. American Journal of Diseases of Children, 143, 1081-1086.
Filho, C., Gomes, A., Bodanese, R., Silva, T., Laufer, T., Alvares, J. P., et al. (2005). Comparison of risperidone and methylphenidate for reducing ADHD symptoms in children and adolescents with moderate mental retardation. Journal of the American Academy of Child & Adolescent Psychiatry, 44, 748-755.
Finck, S., Metz-Lutz, M. N., Becache, E., Danion, A., Vuillemin, M. O., & Marescaux, C. (1995). Attention Deficit Hyperactivity Disorder in epileptic children: A new indication for methylphenidate? Annals of Neurology, 38, 520.
Firestone, P., Musten, L. M., Pisterman, S., Mercer, J., & Bennett, S. (1998). Short-term side effects of stimulant medication are increased in preschool children with Attention-Deficit/Hyperactivity Disorder: a double-blind placebo-controlled study. Journal of Child & Adolescent Psychopharmacology, 8, 13-25.
Fitzpatrick, P. A., Klorman, R., Brumaghim, J. T., & Borgstedt, A. D. (1992). Effects of sustained-release and standard preparations of methylphenidate on Attention Deficit Disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 31, 226-234.
Fox, M., Foster, C., & Zito, J. (2000). Building pharmacoepidemiological capacity to monitor psychotropic drug use among children enrolled in Medicaid. American Journal of Medical Quality, 15, 126-136.
Frankenberger, W., & Cannon, C. (1999). Effects of Ritalin on academic achievement from first to fifth grade. International Journal of Disability, Development & Education, 46, 199-221.
Frankenberger, W., Farmer, C., Parker, L., & Cermak, J. (2001). The use of stimulant medication for treatment of Attention-Deficit/Hyperactivity Disorder: A survey of school psychologists’ knowledge, attitudes, and experience. Developmental Disabilities Bulletin, 29, 132-151.
Frankenberger, W., Lozar, B., & Dallas, P. (1990). The use of medication to treat Attention Deficit Hyperactive Disorder (ADHD) in elementary school children. Developmental Disabilities Bulletin, 18, 1-13.
Frierson, R. L., Wey, J., & Tabler, J. B. (1991). Psychostimulants for depression in the medically ill. American Family Physician, 43, 163-170.
Gadow, K. D. (1985). Prevalence and efficacy of stimulant drug use with mentally retarded children and youth. Psychopharmacology Bulletin, 21, 291-303.
Gadow, K. D. (1992). Pediatric psychopharmacology: A review of recent research. Journal of Child Psychology & Psychiatry, 33, 153-195.
Gadow, K. D., Nolan, E., Sprafkin, J., & Sverd, J. (1995). School observations of children with Attention-Deficit Hyperactivity Disorder and comorbid tic disorder: Effects of methylphenidate treatment. Journal of Developmental & Behavioral Pediatrics, 16, 167-176.
Gadow, K. D., Sverd, J., Sprafkin, J., Nolan, E. E., & Ezor, S. N. (1995). Efficacy of methylphenidate for Attention-Deficit Hyperactivity Disorder in children with tic disorder. Archives of General Psychiatry, 52, 444-455.
Gadow, K. D., Sverd, S., Sprafkin, J., Nolan, E. E., & Grossman, S. (1999). Long-term methylphenidate therapy in children with comorbid Attention-Deficit Hyperactivity Disorder and chronic multiple tic disorder. Archives of General Psychiatry, 56, 330-336.
Gerardin, P., Cohen D., Mazet P., & Flament, M. F. (2002). Drug treatment of conduct disorder in young people. European Neuropsychopharmacology, 12, 361-370.
Giedd, J. N., Blumenthal, J., Molloy, E., & Castellanos, F. X. (2001). Brain imaging of attention deficit/hyperactivity disorder. Annals of the New York Academy of Sciences, 931, 33-49.
Gillberg, C., Melander, H., von Knorring, A., Janols, L. O., Thernlund, G., Hägglöf, B., et al. (1997). Long-term stimulant treatment of children with Attention-Deficit/Hyperactivity Disorder: A randomized double-blind placebo-controlled trial. Archives of General Psychiatry, 54, 857-864.
Gillberg, C., Persson, E., Grufman, M., & Themner, U. (1986). Psychiatric disorders in mildly and severely mentally retarded urban children and adolescents: Epidemiological aspects. British Journal of Psychiatry, 149, 68-74.
Gilligan, J., & Lee, B. (2004). The psychopharmacologic treatment of violent youth. Annals of the New York Academy of Sciences, 1036, 356-381.
Gimpel, G. A., Collett, B. R., Veeder, M. A., Gifford, J. A., Sneddon, P., Bushman, B., et al. (2005). Effects of stimulant medication on cognitive performance of children with ADHD. Clinical Pediatrics, 44, 405-411.
Gittleman, R., Klein, D. F., & Feingold, J. (1983). Children with reading disorders II: Effects of methylphenidate in combination with reading remediation. Journal of Children, Psychology, & Psychiatry, 24, 193-212.
Goldberg, J. (2002). Clonidine and methylphenidate were effective for Attention Deficit Hyperactivity Disorder in children with comorbid tics. Evidence Based Mental Health, 5, 122.
Golden, G. S. (1988). The relationship between stimulant medication and tics. Pediatric Annals, 17, 405-408.
Grcevich, S., Rowane, W. A., & Marcellino, B. (2001). Retrospective comparison of Adderall and methylphenidate in the treatment of Attention Deficit Hyperactivity Disorder. Journal of Child & Adolescent Psychopharmacology, 11, 35-41.
Greenhill, L. L. (2002). Efficacy and safety of OROS MPH in adolescents with ADHD. Presented at 49th Annual Meeting of the American Academy of Child & Adolescent Psychiatry, San Francisco, CA, October 22-27.
Greenhill, L. L., Abikoff, H. B., Arnold, L. E., Cantwell, D. P., Conners, C. K., Elliott, G., et al. (1996). Medication treatment strategies in the MTA Study: Relevance to clinicians and researchers. Journal of the American Academy of Child & Adolescent Psychiatry, 35, 1304-1313.
Greenhill, L. L., Pliska, S., Dulcan, M. K., Bernet, W., Arnold, V., Beitchman, J., et al. (2002). Practice parameter for use of stimulant medications in the treatment of children, adolescents, and adults. Journal of the American Academy of Child & Adolescent Psychiatry, 41, 26S-49S.
Greenhill, L. L., Swanson, J. M., Vitiello, B., Davies, M., Clevenger, W., Wu, M., et al. (2001). Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA Titration Trial. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 180-187.
Grimwood, K., Anderson, P., Anderson, V., Tan, L., & Nolan, T. (2000). Twelve-year outcomes following bacterial meningitis: Further evidence for persisting effects. Archives of Disease in Childhood, 83, 111-116.
Gross-Tsur, V., Manor, O., van der Meere, J., Joseph, A., & Shalev, R. S. (1997). Epilepsy and Attention Deficit Hyperactivity Disorder: Is methylphenidate safe and effective? Journal of Pediatrics, 130, 670-674.
Gureasko-Moore, D. P., DuPaul, G. J., & Power, T. J. (2005). Stimulant treatment for Attention-Deficit/Hyperactivity Disorder: Medication monitoring practices of school psychologists. School Psychology Review, 34, 232-245.
Hechtman, L., Weiss, G., Perlman, T., & Amsel, R. (1984). Hyperactives as young adults: initial predictors of adult outcome. Journal of the American Academy of Child Psychiatry, 23, 250-260.
Hamarman, S., Fossella, J., Ulger, C., Brimacombe, M., & Dermody, J. (2004). Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with Attention Deficit Hyperactivity Disorder: A pharmacogenetic study. Journal of Child & Adolescent Psychopharmacology, 14, 564-574.
Handen, B. L., Breaux, A. M., Gosling, A., Ploof, D. L., & Feldman, H. (1990). Efficacy of methylphenidate among mentally retarded children with Attention Deficit Hyperactivity Disorder. Pediatrics, 86, 922-930.
Handen, B. L., Breaux, A. M., Janosky, J., McAuliffe, S., Feldman, H., & Gosling, A. (1992). Effects and noneffects of methylphenidate in children with mental retardation and ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 31, 455-461.
Handen, B. L., Feldman, H., Gosling, A., Breaux, A. M., & McAuliffe, S. (1991). Adverse side effects of methylphenidate among mentally retarded children with ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 30, 241-245.
Handen B. L., Feldman, H. M., Lurier A., & Murray, P. J. (1999). Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 38, 805-812.
Hanisch, C., Konrad, K., Gunther, T., & Herpertz-Dahlmann, B. (2004). Age-dependent neuropsychological deficits and effects of methylphenidate in children with Attention-Deficit/Hyperactivity Disorder: A comparison of pre- and grade-school children. Journal of Neural Transmission, 111, 865-881.
Hechtman, L., Abikoff, H., Klein, R. G., Weiss, G., Respitz, C., Kouri, J., et al. (2004). Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child Adolescence & Psychiatry, 43, 812-819.
Hechtman, L., & Greenfield, B. (2003). Adult Attention Deficit/Hyperactivity Disorder: Recognition and treatment. Contemporary Psychiatry, 1, 1-10.
Hesslinger, B., Tebartz van Elst, L., Thiel, T., Haegele, K., Hennig, J., & Ebert, D. (2002). Frontoorbital volume reductions in adult patients with Attention Deficit Hyperactivity Disorder. Neuroscience Letters, 328, 319-321.
Hinshaw, S. P. (1991). Stimulant medication and the treatment of aggression in children with attentional deficits. Journal of Clinical Child Psychology, 20, 301-312.
Hinshaw, S. P., & Melnick, S. (1995). Peer relationships in children with Attention-Deficit Hyperactivity Disorder with and without comorbid aggression. Developmental Psychopathology, 7, 627-647.
Hinshaw, S. P., Heller, T., & McHale, J. P. (1992). Covert antisocial behavior in boys with Attention-Deficit Hyperactivity Disorder: External validation and effects of methylphenidate. Journal of Consulting & Clinical Psychology, 60, 274-281.
Hinshaw, S. P., Henker, B., & Whalen, C. K. (1984). Self-control in hyperactive boys in anger-inducing situations: Effects of cognitive-behavioral training and of methylphenidate. Journal of Abnormal Child Psychology, 12, 155-177.
Hinshaw, S. P., Henker, B., Whalen, C. K., Erhardt, D., & Dunnington, R. E., Jr. (1989). Aggressive, prosocial, and nonsocial behavior in hyperactive boys: Dose effects of methylphenidate in naturalistic settings. Journal of Consulting & Clinical Psychology, 57, 636-643.
Hinshaw, S. P., Owens, E. B., Wells, K. C., Kraemer, H. C., Abikoff, H. B., Arnold L. E., et al. (2000). Family processes and treatment outcome in the MTA: Negative/ineffective parenting practices in relation to multimodal treatment. Journal of Abnormal Child Psychology, 28, 555-568.
Hodgens, J. B., Cole, J., & Boldizar, J. (2000). Peer-based differences among children with ADHD. Journal of Clinical Child Psychology, 29, 443-452.
Hood, J., Rankin, P., & Isaacs, E. (2005). Immediate effects of methylphenidate on cognitive attention skills of children with Attention Deficit Hyperactivity Disorder. Developmental Medicine & Child Neurology, 47, 408-414.
Hornyak, J. E., Nelson, V. S., & Hurvitz, E. A. (1997). The use of methylphenidate in pediatric traumatic brain injury. Pediatric Rehabilitation, 1, 15-17.
Hoza, B., Gerdes, A. C., Mrug, S., Hinshaw, S. P., Bukowski, W. M., Gold, J. A., et al. (2005). Peer-assessed outcomes in the Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder. Journal of Clinical Child & Adolescent Psychology, 34, 74-86.
Huesmann, L. R., Lagerspetz, K., & Eron, L. D. (1984). Intervening variables in the TV violence-aggression relation: Evidence from two countries. Developmental Psychology, 20, 746-775.
Hupp, S. D., Reitman, D., Northup, J., O’Callaghan, P. M., & LeBlanc, M. (2002). The effects of delayed rewards, tokens, and stimulant medication on sportsmanlike behavior with ADHD-diagnosed children. Behavior Modification, 26, 148-162.
Huss, M., & Lehmkuhl, U. (2002). Methylphenidate and substance abuse: A review of pharmacology, animal and clinical studies. Journal of Attention Disorders, 6:(suppl. 1), S65-S71.
Jacobvitz, D., Sroufe, A., Stewart, M., & Leffert, N. (1990). Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: A comprehensive review. Journal of the American Academy of Child & Adolescent Psychiatry, 29, 677-688.
Jadad, A. R., Booker, L., Gauld, M., Kakuma, R., Boyle, M., Cunningham, C. E., et al. (1999). The treatment of Attention-Deficit Hyperactivity Disorder: An annotated bibliography and critical appraisal of published systematic reviews and meta-analyses. Canadian Journal of Psychiatry, 44, 1025-1035.
James, R. S., Sharp, W. S., Bastain, T. M., Lee, P. P., Walter, J. M., Czarnowlewski, M., et al. (2001). Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 1268-1276.
Jensen, P. S. (2001). ADHD comorbidity and treatment outcomes in the MTA. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 134-136.
Jensen, P. S., Bhatara, V. S., Vitiello, B., Hoagwood, K., Feil, M., & Burke, L. B. (1999). Psychoactive medication prescribing practices for U.S. children: Gaps between research and clinical practice.Journal of the American Academy of Child & Adolescent Psychiatry, 38, 557-565.
Jensen, P. S., Hinshaw, S. P., Swanson, J. M., Greenhill, L. L., Conners, C. K., Arnold, L. E., et al. (2001a). Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and applications for primary care providers. Journal of Developmental & Behavioral Pediatrics, 22, 60-73.
Jensen, P. S., Hinshaw, S. P., Kraemer, H. C., Lenora, N., Newcorn, J. H., Abikoff, H. B., et al. (2001b). ADHD comorbidity findings from the MTA study: Comparing comorbid subgroups. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 147-158.
Johnson, C. R., Handen, B. L., Lubetsky, M. J., & Sacco, K. A. (1994). Efficacy of methylphenidate and behavioral intervention on classroom behavior in children with ADHD and mental retardation. Behavior Modification, 18, 470-487.
Johnston, C., Pelham, W. E., Hoza, J., & Sturges, J. (1988). Psychostimulant rebound in Attention Deficit disordered boys. Journal of the American Academy of Child & Adolescent Psychiatry, 27, 806-810.
Johnston, C., Seipp, C., Hommersen, P., Hoza, B., & Fine, S. (2005). Treatment choices and experiences in Attention Deficit and Hyperactivity Disorder: Relations to parents’ beliefs and attributions. Child Care & Health Development, 31, 669-677.
Jonkman, L. M., Kemner, C., Verbaten, M. N., van Engeland, H., Kenemans, J. L., Camfferman, G., et al. (1999). Perceptual and response interference in children with Attention-Deficit Hyperactivity Disorder and the effects of methylphenidate. Psychophysiology, 36, 419-429.
Joyce, P. R., Donald, R. A., Nicholls, M. G., Livesey, J. H., & Abbott, R. M. (1986). Endocrine and behavioral responses to methylphenidate in normal subjects. Biological Psychiatry, 21, 1015-1023.
Kajs-Wyllie, M. (2002). Ritalin revisited: does it really help in neurological injury? Journal of Neuroscience Nursing, 34, 303-313.
Kaminester, D. D. (1997). Attention Deficit Hyperactivity Disorder and methylphenidate: When society misunderstands medicine. McGill Journal of Medicine, 3, 105-114.
Kaplan, S., Heiligenstein, J., West, S., Busner, J., Harder, D., Dittman, R., et al. (2004). Efficacy and safety of atomoxetine in childhood Attention-Deficit/Hyperactivity Disorder with comorbid oppositional defiant disorder. Journal of Attention Disorders, 8, 45-52.
Kates, W. R., Frederikse, M., Mostofsky, S. H., Folley, B. S., Cooper, K., Mazur-Hopkins, P., et al. (2002). MRI parcellation of the frontal lobe in boys with Attention Deficit Hyperactivity Disorder or Tourette Syndrome. Psychiatry Research, 116, 63-81.
Kempton, S., Vance, A., Maruff, P., Luk, E., Costin, J., & Pantelis, C. (1999). Executive function and Attention Deficit Hyperactivity Disorder: Stimulant medication and better executive function performance in children. Psychological Medicine, 29, 527-538.
Kilpelainen, R., Luoma, L., Herrgard, E., Ypparila, H., Partanen, J., & Karhu, J. (1999). Persistent frontal P300 brain potential suggests abnormal processing of auditory information in distractible children. Neuroreport, 10, 3405-3410.
Klassen, A., Miller, A., Raina, P., Lee, S. K., & Olsen, L. (1999). Attention-Deficit Hyperactivity Disorder in children and youth: A quantitative systematic review of the efficacy of different management strategies. Canadian Journal of Psychiatry, 44, 1007-1016.
Klein, R. G., & Abikoff, H. (1997). Behavior therapy and methylphenidate in the treatment of children with ADHD. Journal of Attention Disorders, 2, 89-114.
Klein, R. G., Abikoff, H., Klass, E., Ganeles, D., Seese, L. M., & Pollack, S. (1997). Clinical efficacy of methylphenidate in conduct disorder with and without Attention Deficit Hyperactivity Disorder. Archives of General Psychiatry, 54, 1073-1080.
Klein-Schwartz, W. (2002). Abuse and toxicity of methylphenidate. Current Opinion in Pediatrics, 14, 219-223.
Klorman, R. (1986). Attention Deficit Disorder in adolescence. In R. A. Feldman & A. R. Stiffman (Eds.), Advances in adolescent mental health (Vol. 1, pp. 19-62). Greenwhich, CT: JAI Press.
Klorman, R., Brumaghim, J. T., Fitzpatrick, P. A., & Borgstedt, A. D. (1991). Methylphenidate speeds evaluation processes of Attention Deficit Disorder adolescents during a continuous performance test. Journal of Abnormal Child Psychology, 19, 263-283.
Kollins, S. H. (2004). Methodological issues in the assessment of medication effects in children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). Journal of Behavioral Education, 13, 247-266.
Kollins, S. H., Rush, C. R., Pazzaglia, P. J., & Ali, J. A. (1998). Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate. Experimental & Clinical Psychopharmacology, 6, 367-374.
Konrad, K., Gunther, T., Hanisch, C., & Herpertz-Dahlmann, B. (2004). Differential effects of methylphenidate on attentional functions in children with Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 43, 191-198.
Kurlan, R. (1997). Tourette syndrome: Treatment of tics. Neurologic Clinics, 15, 403-409.
Kurlan, R. (2003). Tourette’s syndrome: Are stimulants safe?Current Neurology & Neuroscience Reports, 3, 285-288.
Kutcher, S., Aman, M., Brooks, S. J., Buitelaar, J., van Daalen, E., Fegert, J., et al. (2004). International consensus statement on Attention-Deficit/Hyperactivity Disorder (ADHD) and disruptive behaviour disorders (DBDs): Clinical implications and treatment practice suggestions. European Journal of Neuropsychopharmacology, 14, 11-28.
Law, S. F., & Schachar, R. J. (1999). Do typical clinical doses of methylphenidate cause tics in children treated for Attention-Deficit Hyperactivity Disorder? Journal of the American Academy of Child & Adolescent Psychiatry, 38, 944-951.
Lawrence, C. A., Barry, R. J., Clarke, A. R., Johnstone, S. J., McCarthy, R., Selikowitz, M., et al. (2005). Methylphenidate effects in Attention Deficit/Hyperactivity Disorder: Electrodermal and ERP measures during a continuous performance task. Psychopharmacology (Berl), 183, 81-91.
LeFever, G. B., Arcona, A. P., & Antonuccio, D. O. (2003). ADHD among American schoolchildren: Evidence of overdiagnosis and overuse of medication. Scientific Review of Mental Health Practice, 2, 105-122.
Lerer, R. J., Artner, J., & Lerer, M. P. (1979). Handwriting deficits in children with minimal brain dysfunction: Effects of methylphenidate (Ritalin) and placebo. Journal of Learning Disabilities, 12, 450-455.
Lerer, R. J., & Lerer, P. (1976). The effects of methylphenidate on the soft neurological signs of hyperactive children. Pediatrics, 57, 521-525.
Loney, J., & Milich, R. (1982). Hyperactivity, inattention, and aggression in clinical practice. In M. Wolraich, & D. Routh (Eds.), Advances in development and behavioral pediatrics (Vol. 3, pp. 113-147). Greenwich, CT: JAI Press.
Mahalick, D. M., Carmel, P. W., Greenberg, J. P., Molofsky, W., Brown, J. A., Heary, R. F., et al. (1998). Psychopharmacologic treatment of acquired attention disorders in children with brain injury. Pediatric Neurosurgery, 29, 21-26.
Mann, C. A., Lubar, J. F., Zimmerman, A. W, Miller, C. A., & Muenchen, R. A. (1992). Quantitative analyses of EEG in boys with Attention Deficit Hyperactivity Disorder: A controlled study with clinical implications. Pediatric Neurology, 8, 3036.
Mannuzza, S., Klein, R. G., & Moulton, J. L. (2003). Does stimulant treatment place children at risk for adult substance abuse? A controlled, prospective follow-up study. Journal of Child & Adolescent Psychopharmacology, 13, 273-282.
March, J. S. Swanson, J. M., Arnold, L. E., Hoza, B., Conners, C. K., Hinshaw, S. P., et al. (2000). Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA). Journal of Abnormal Child Psychology, 28, 527-541.
Matier, K., Halperin, J. M., Sharma, V., Newcorn, J. H., & Sathaye, N. (1992). Methylphenidate response in aggressive and nonaggressive ADHD children: Distinctions on laboratory measures of symptoms. Journal of the American Academy of Child & Adolescent Psychiatry, 31, 219-225.
McCormick, L. H. (2003). ADHD treatment and academic performance: A case series. Journal of Family Practice, 52, 620-626.
McGough, J. J. (2005). Attention-Deficit/Hyperactivity Disorder pharmacogenomics. Biological Psychiatry, 57, 1367-1373.
McMaster University Evidence-Based Practice Center. (1999). Treatment of Attention-Deficit Hyperactivity Disorder. Evidence Report/Technology Assessment no. 11, AHCPR Publication No. 99-E018. Rockville, MD: Agency for Health Care Policy & Research.
McNeal R. E., Roberts, M. C., & Barone V. J. (2000). Mothers’ and children’s perceptions of medication for children with Attention-Deficit Hyperactivity Disorder. Child Psychiatry & Human Development, 30, 173-187.
Mehta, M. A., Goodyer, I. M., & Sahakian, B. J. (2004). Methylphenidate improves working memory and set-shifting in AD/HD: Relationships to baseline memory capacity. Journal of Child Psychology & Psychiatry & Allied Disciplines, 45, 293-305.
Milberger, S., Biederman, J., Faraone, S. V., Chen, L., & Jones, J. (1997). ADHD is associated with early initiation of cigarette smoking in children and adolescents. Journal of Academic Child Adolescent Psychiatry, 36, 37-44.
Milch, R., & Landau, S. (1982). Socialization and peer relations hyperactive children. In K. D. Gadow, & I. Bialer (Eds.),Advances in learning and behavioral disabilities: A recent annual (Vol. 1, pp. 283-339). Greenwich, CT: JAI Press.
Miller, L. S., Koplewicz, H. S., & Klein, R. G. (1997). Teacher ratings of hyperactivity, inattention, and conduct problems in preschoolers. Journal of Abnormal Child Psychology, 25, 113-119.
Modi, N. B., Lindemulder, B., & Gupta, S. K. (2000). Single- and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS (methylphenidate HCl) formulation. Journal of Clinical Pharmacology, 40, 379-388.
Moleski, M. (2000). Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Archives of Clinical Neuropsychology, 15, 603-630.
Moline, S., & Frankenberger, W. (2001). Use of stimulant medication for treatment of Attention-Deficit/Hyperactivity Disorder: A survey of middle and high school students’ attitudes. Psychology in the Schools, 38, 569-584.
Morris, R. D., Krawiecki, N. S., Kullgren, K. A., Ingram, S. M., & Kurcynski, B. (2000). Brain tumors. In K. O. Yeates, M. D. Ris, & H. G. Taylor (Eds.), Pediatric Neuropsychology (pp. 74-91). New York: Guilford Press.
Moser, S. E., & Bober, J. F. (2002). Behavioral problems in children and adolescents. In R. E. Rakel (Ed.), Textbook of family practice (6th ed.) (pp. 641-644). Philadelphia: W. B. Saunders.
Mostofsky, S. H., Cooper, K. L., Kates, W. R., Denckla, M. B., & Kaufmann, W. E. (2002). Smaller prefrontal and premotor volumes in boys with Attention-Deficit/Hyperactivity Disorder, Biological Psychiatry, 52, 785-794.
MTA Cooperative Group. (1999a). A 14-month randomized clinical trial of treatment strategies for Attention-Deficit Hyperactivity Disorder (ADHD). Archives of General Psychiatry, 56, 1073-1086.
MTA Cooperative Group. (1999b). Moderators and mediators of treatment response for children with Attention-Deficit/Hyperactivity Disorder: The multimodal treatment study of children with Attention-Deficit/Hyperactivity Disorder. Archives of General Psychiatry, 56, 1088-1096.
MTA Cooperative Group. (2004a). National Institute of Mental Health Multimodal Treatment Study of ADHD: 24-Month outcomes of treatment strategies for ADHD. Pediatrics, 113, 754-760.
MTA Cooperative Group. (2004b). National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: Changes in effectiveness and growth after the end of treatment. Pediatrics, 113, 762-769.
Mulas, F., Capilla, A., Fernandez, S., Etchepareborda, M. C., Campo, P., Maestu, F., et al. (2006). Shifting-related brain magnetic activity in Attention-Deficit/Hyperactivity Disorder. Biological Psychiatry, 59, 373-379.
Mulhern, R. K., White, H. A., Glass, J. O., Kun, L. E., Leigh, L., Thompson, S. J., et al. (2004). Attentional functioning and white matter integrity among survivors of malignant brain tumors of childhood. Journal of the International Neuropsychological Society, 10, 180-189.
Musten, L. M., Firestone, P., Pisterman, S., Bennett, S., & Mercer, J. (1997). Effects of methylphenidate on preschool children with ADHD: Cognitive and behavioral functions. Journal of the American Academy of Child & Adolescent Psychiatry, 36, 1407-1415.
Nangle, D. W., & Erdley, C. A. (Eds.). (2001). New directions for child and adolescent development: The role of friendship in psychological adjustment. San Francisco: Jossey-Bass.
Newcorn, J. H., Halperin, J. M., Jensen, P. S., Abikoff, H. B., Arnold, E., Cantwell, D. P., et al. (2001). Symptom profiles in children with ADHD: Effects on comorbidity and gender. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 137-146.
Oades, R. D., Dittman-Balcar, A., Schepker, R., Eggers, C., & Zerbin, D. (1996). Auditory event-related potentials (erps) and mismatch negativity (mmn) in healthy children and those with Attention-Deficit or Tourette/tic symptoms. Biological Psychology, 12, 163-185.
O’Driscoll, G. A., Depatie, L., Holahan, A. V., Savion-Lemieux, T., Barr, R. G., Jolicoeur, C., et al. (2005). Executive functions and methylphenidate response in subtypes of Attention-Deficit/Hyperactivity Disorder. Biological Psychiatry, 57, 1452-1460.
Overmeyer, S., Bullmore, E. T., Suckling, J., Simmons, A., Williams, S. C., Santosh, P. J., et al. (2001). Distributed grey and white matter deficits in Hyperkinetic Disorder: MRI evidence for anatomical abnormality in an attentional network. Psychological Medicine, 31, 1425-1435.
Palumbo, D., Spencer, T., Lynch, J., Co-Chien, H., & Faraone, S. V. (2004). Emergence of tics in children with ADHD: Impact of once-daily OROS methylphenidate therapy. Journal of Child & Adolescent Psychopharmacology, 14, 185-194.
Patrick, K. S., Muellar, R. A., Gualtieri, C. T., & Breese, G. R. (1987). Pharmacokinetics and actions of methylphenidate. In H. Y. Meltzer (Ed.), Psychopharmacology: the third generation of progress (pp. 1387-1395). New York: Raven.
Pearson, D. A., Santos, C. W., Casat, C. D., Jerger, S. W., Loveland, K. A., Faria, L. P., et al. (2004). Treatment effects of methylphenidate on cognitive functioning in children with mental retardation and ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 43, 677-685.
Pearson, D. A., Santos, C. W., Roache, J. D., Casat, C. D., Loveland, K. A., Lachar, D., et al. (2003). Treatment effects of methylphenidate on behavioral adjustment in children with mental retardation and ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 42, 209-216.
Peeples, E. E., Searls, D. T., & Wellingham, J. P. (1995). Attention-Deficit Hyperactivity Disorder: A longitudinal case study of handwriting characteristics.Perceptual & Motor Skills, 81, 1243-1252.
Pelham, W. E., Jr. (2000). Implications of the MTA study for behavioral and combined treatments. The ADHD Report, 8, 9-16.
Pelham, W. E., Aronoff, H. R., Midlam, J. K., Shapiro, C. J., Gnagy, E. M., Chronis, A. M., et al. (1999). A comparison of Ritalin and Adderall: Efficacy and time-course in children with Attention-Deficit/Hyperactivity Disorder. Pediatrics, 103, 43.
Pelham, W. E., Bender, M. E., Caddell, J., Booth, S., & Moorer, S. H. (1985). Methylphenidate and children with Attention Deficit Disorder: Dose effects on classroom academic and social behavior. Archives of General Psychiatry, 42, 948-952.
Pelham, W. E. Jr., Carlson, C., Sams, S. E., Vallano, G., Dixon, M. J., & Hoza, B. (1993). Separate and combined effects of methylphenidate and behavior modification on boys with Attention Deficit-Hyperactivity Disorder in the classroom. Journal of Consulting & Clinical Psychology, 61, 506-515.
Pelham, W. E., Fabiano, G. A., & Massetti, G. M. (2005). Evidence-based assessment of Attention Deficit Hyperactivity Disorder in children and adolescents. Journal of Clinical Child & Adolescent Psychology, 34, 449-476.
Pelham, W. E., Gnagy, E. M., Burrows-Maclean, L., Williams, A., Fabiano, G. A., Morrisey, S. M., et al. (2001). Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics, 107, 105.
Pelham, W. E., Greenslade, K. E., Vodde-Hamilton, M. A., Murphy, D. A., Greenstein, J. J., Gnagy, E. M., et al. (1990). Relative efficacy of long-acting CNS stimulants on children with Attention Deficit-Hyperactivity Disorder: A comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline. Pediatrics, 86, 226-237.
Pelham, W. E., & Hoza, J. (1987). Behavioral assessment of psychostimulant effects on ADHD children in a summer day treatment program. In R. Prinz (Ed.), Advances in behavioral assessment of children and families (Vol. 3, pp. 3-33). Greenwich, CT: JAI Press.
Pelham, W. E., & Murphy, H. A. (1986). Attention deficit and conduct disorders. In M. Hersen (Ed.), Pharmacological and behavioral treatment: An integrative approach (pp. 108-148). New York: Wiley.
Pelham, W. E., Jr., Swanson, J. M., Furman, M. B., & Schwindt, H. (1995). Pemoline effects on children with ADHD: A time-response by dose-response analysis on classroom measures. Journal of the American Academy of Child & Adolescent Psychiatry, 34, 1504-1513.
Peloquin, L., & Klorman, R. (1986). Effects of methylphenidate on normal children’s moods, event-related potentials, and performance in memory, scanning and vigilance. Journal of Abnormal Psychology, 95, 88-98.
Phelps, L., Brown, R. T., & Power, T. J. (2002). Pediatric psychopharmacology: Combining medical and psychosocial interventions. Washington, DC: American Psychological Association.
Pfiffner, L. J., Calzada, E., & McBurnett, K. (2000). Interventions to enhance social competence. Child & Adolescent Psychiatric Clinics of North America, 9, 689-709.
Pliszka, S. R. (2000). Patterns of comorbidity with Attention-Deficit/Hyperactivity Disorder. Child & Adolescent Psychiatric Clinics of North America, 9, 525-540.
Pliszka, S. R., Browne, R. G., Olvera, R. L., & Wynne, S. K. (2000). A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of Attention Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 39, 619-626.
Pliszka, S. R., Greenhill, L. L., Crimson, M. L., Sedillo, A., Carlson, C., Conners, K. C., et al. (2000). The Texas children’s medication algorithm project: Report of the Texas consensus conference panel on medication treatment of childhood Attention-Deficit/Hyperactivity Disorder. Part I. Journal of the American Academy of Child & Adolescent Psychiatry, 39, 908-919.
Poulton, A. (2005). Growth on stimulant medication; clarifying the confusion: A review. Archive of Disease in Childhood, 90, 801-806.
Rappley, M. D., Mullan, P. B., Alvarez, F. J., Eneli, I. U., Wang, J., & Gardiner, J. C. (1999). Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children. Archives of Pediatric and Adolescent Medicine, 153, 1039-1045
Rapport, M. D., Denney, C., DuPaul, G. J., & Gardner, M. J. (1994). Attention Deficit Disorder and methylphenidate: Normalization rates, clinical effectiveness, and response prediction in 76 children. Journal of the American Academy of Child & Adolescent Psychiatry, 33, 882-893.
Rapport, M. D., DuPaul, G. J., & Kelly, K. L. (1989). Attention Deficit Hyperactivity Disorder and methylphenidate: The relationship between gross body weight and drug response in children. Psychopharmacology Bulletin, 25, 285-290.
Rapport, M. D., & Kelly, K. L. (1991). Psychostimulant effects on learning and cognitive function: Findings and implications for children with Attention Deficit Hyperactivity Disorder. Clinical Psychology Review, 11, 61-92.
Reitman, D., Hupp, S. D. A., O’Callaghan, P. M., Gulley, V., & Northup, J. (2001). The influence of a token economy and methylphenidate on attentive and disruptive behavior during sports with ADHD-diagnosed children. Behavior Modification, 25, 305-323.
Richters, J. E., Eugene, A. L., Jensen, P. S., Abikoff, H., Conners, K. C., Greenhill, L. L., et al. (1995). NIMH collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale. Journal of the American Academy of Child & Adolescent Psychiatry, 34, 987-1000.
Riordan, H. J., Flashman, L. A., Saykin, A. J., Frutiger, S. A., Carroll, K. E., & Huey, L. (1999). Neuropsychological correlates of methylphenidate treatment in adult ADHD with and without depression. Archives of Clinical Neuropsychology, 14, 217-233.
Robison, L. M., Sclar, D. A., Skaer, T. L., & Galin, R. S. (1999). National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school age children: 1990-1995. Clinical Pediatrics (Phila), 38, 209-217.
Roman, T., Schmitz, M., Polanczyk, G. V., Eizirik, M., Rohde, L. A., & Hutz, M. H. (2002). Further evidence for the association between Attention-Deficit/Hyperactivity Disorder and the dopamine-beta-hydroxylase gene. American Journal of Medical Genetics, 114, 154-158.
Rubia, K., Noorlos, J., Smith, A., Gunning, B., & Sergeant, J. (2003). Motor timing deficits in community and clinical boys with hyperactive behavior: The effect of methylphenidate on motor timing. Journal of Abnormal Child Psychology, 31, 301-313.
Rugino, T. A., & Samsock, T. C. (2003). Modafinil in children with Attention-Deficit Hyperactivity Disorder. Pediatric Neurology, 29, 136-142.
Runnheim, V. A., Frankenberger, W. R., & Hazelkorn, M. N. (1996). Medicating students with emotional and behavioral disorders and ADHD: A state survey. Behavioral Disorder, 21, 306-314.
Rutter, M. (1983). School effects on pupil progress: Research findings and policy implications. Child Development, 54, 1-29.
Safer, D. J., & Krager, J. M. (1988). A survey of medication treatment for hyperactive/inattentive students. Journal of the American Medical Association, 260, 2256-2258.
Safer, D. J., Zito, J. M., & Fine, E. M. (1996). Increased methylphenidate usage for Attention Deficit Disorder in the 1990s. Pediatrics, 98, 1084-1088.
Samuels, J. A., Franco, K., Wan, F., & Sorof, J. M. (2005). Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: A double-blind, randomized, cross-over trial. Pediatric Nephrology, 21, 92-95.
Sane, N., & McGough, J. J. (2002). MethyPatch Noven. Current Opinion in Investigational Drugs, 3, 1222-1224.
Santosh, P. J., & Taylor, E. (2000). Stimulant drugs. European Journal of Child & Adolescent Psychiatry, 9, 27-43.
Satel, S. L., & Nelson, J. C. (1989). Stimulants in the treatment of depression: A critical overview. Journal of Clinical Psychiatry, 50, 241-249.
Satterfield, J. H. (1990). BEAM studies in ADD boys. In K. Conners, & M. Kinsbourne (Eds.), Attention Deficit Hyperactivity Disorder (pp. 127-136). Munich: Medizine Verlag Munchen.
Satterfield, J. H., & Cantwell, D. P. (1974). Proceedings: CNS function and response to methylphenidate in hyperactive children. Psychopharmacology Bulletin, 10, 36-77.
Satterfield, J. H., Schell, A. M., & Nicholas, T. (1994). Preferential neural processing of attended stimuli in Attention-Deficit Hyperactivity Disorder and normal boys. Psychophysiology, 31, 1-10.
Schachar, R., Jadad, A. R., Gauld, M., Boyle, M., Booker, L., Snider, A., et al. (2002). Attention-Deficit Hyperactivity Disorder: Critical appraisal of extended treatment studies. Canadian Journal of Psychiatry, 47, 337-348.
Schachter, H. M., Pham, B., King, J., Langford, S., & Moher, D. (2001). How efficacious and safe is short-acting methylphenidate for the treatment of Attention-Deficit Disorder in children and adolescents? A meta-analysis. Canadian Medical Association Journal, 165, 1475-1488.
Scheres, A., Oosterlaan, J., Swanson, J., Morein-Zamir, S., Meiran, N., Schut, H., et al. (2003). The effect of methylphenidate on three forms of response inhibition in boys with AD/HD. Journal of Abnormal Child Psychology, 31, 105-120.
Schachar, R. J., Tannock, R., Cunningham, C., & Corkum, P. V. (1997). Behavioral, situational and temporal effects of treatment of ADHD with methylphenidate. Journal of the American Academy of Child & Adolescent Psychiatry, 36, 754-763.
Seifert, J., Scheuerpflug, P., Zillessen, K. E., Fallgater, A., & Warnke, A. (2003). Electrophysiological investigation of the effectiveness of methylphenidate in children with and without ADHD. Journal of Neural Transmission, 110, 821-829.
Selikowitz, M. (2004). ADHD: The facts. Oxford: Oxford University Press.
Sergeant, J. A., Oosterlaan, J., & Van der Meere, J. (1999). Information processing and energetic factors in Attention-Deficit/Hyperactivity Disorder. In H. C. Quay, & A. E. Hogan (Eds.), Handbook of disruptive behavior disorders (pp. 75-104). New York: Kluwer Academic/Plenum.
Shafritz, K. M., Marchione, K. E., Gore, J. C., Shaywitz, S. E., & Shaywitz, B. A. (2004). The effects of methylphenidate on neural systems of attention in Attention Deficit Hyperactivity Disorder. American Journal of Psychiatry, 161, 1990-1997.
Sharp, W. S., Walter, J. M. Marsh, W. L., Ritchie, G., Hamburger, S. D., Castellanos, F. (1999). ADHD in girls: Clinical comparability of a research sample. Journal of the American Academy of Child & Adolescent Psychiatry, 38, 40-47.
Shaw, K., Mitchell, G., & Hilton, D. (2000). Are stimulants addictive in children? What the evidence says. Australian Family Physician, 29, 1202-1204.
Sheppard, D. M., Bradshaw, J. L., Georgiou, N., Bradshaw, J. A., & Lee, P. (2000). Movement sequencing in children with Tourette’s Syndrome and Attention Deficit Hyperactivity Disorder. Movement Disorders, 15, 1184-1193.
Short, E. J., Manos, M. J., Findling, R. L., & Schubel, E. A. (2004). A prospective study of stimulant response in preschool children: Insight from ROC analyses. Journal of the American Academy of Child & Adolescent Psychiatry, 43, 251-259.
Siddall, M. (2005). Use of methylphenidate in traumatic brain injury. Annals of Pharmacotherapy, 39, 1309-1313.
Smith, B., Pelham, W., Evans, S., Gnagy, E., Molina, B., Bukstein, O., et al. (1998). Dosage effects of methylphenidate on the social behavior of adolescents diagnosed with Attention-Deficit Hyperactivity Disorder. Experimental & Clinical Psychopharmacology, 6, 187-204.
Smith, B. H., Waschbusch, D. A., Willoughby, M. T., & Evans, S. (2000). The efficacy, safety, and practicality of treatments for adolescents with Attention Deficit/Hyperactivity Disorder (ADHD). Clinical Child & Family Psychology Review, 3, 243-267.
Snider, T. E., Busch, T., & Arrowood, L. (2003). Teacher knowledge of stimulant medication and ADHD. Remedial & Special Education, 24, 46-56.
Soetens, E., Casaer, S., D’Hooge, R., & Hueting, J. E. (1995). Effect of amphetamine on long-term retention of verbal material. Psychopharmacology, 119, 155-162.
Solanto, M. V. (1998). Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behavior and Brain Research, 94, 127-152.
Solanto, M. V., Arnsten, A. F. T., & Castellanos, F. X. (2001). Stimulant drugs and ADHD: Basic and clinical neuroscience. New York: Oxford University Press.
Sonuga-Barke, E. J. S., Swanson, J. S., Coghill, D., DeCory, H. H., & Hatch, S. J. (2004). Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: Preliminary indications from a secondary analysis of the COMACS study data. BMC Psychiatry, 4, 28.
Sowell, E. R., Thompson, P. M., Welcome, S. E., Henkenius, A. L., Toga, A. W., & Peterson, B. S. (2003). Cortical abnormalities in children and adolescents with Attention-Deficit Hyperactivity Disorder. Lancet, 362, 1699-1707.
Spencer, T. J., Biederman, J., Wilens, T., Harding, M., O’Donnell, D., & Griffin, S. (1996). Pharmacotherapy of ADHD across the lifecycle: A literature review. Journal of the American Academy of Child & Adolescent Psychiatry, 35, 409-432.
Sprague, R. L., & Sleator, E. K. (1977). Methylphenidate in hyperkinetic children: Differences in dose effects on learning and social behavior. Science, 198, 1274-1276.
Stein, M. A., & Greenhill, L. L. (2002). Once-daily Concerta (MPH) for adolescents and adults with ADHD. International Journal of Neuropsychopharmacology, 5, S162.
Stein, M. A., Sarampote, C. S., Waldman, I. D., Robb, A. S., Conlon, C., Pearl, P., et al. (2003). A dose-response study of OROS methylphenidate in children with Attention-Deficit/Hyperactivity Disorder. Pediatrics, 112, e404-e413.
Stein, M. A., Waldman, I. D., Sarampote, C. S., Seymour, K. E., Robb, A. S., Conlon, C., et al. (2005). Dopamine transporter genotype and methylphenidate dose response in children with ADHD. Neuropsychopharmacology, 30, 1374-1382.
Steinhoff, K. (2004). Attention-Deficit/Hyperactivity Disorder: Medication treatment-dosing and duration of action. American Journal of Managed Care, 10, 99-106.
Stowe, C. D., Gardner, S. F., Gist, C. C., Schulz, E. G., & Wells, T. G. (2002). 24-hour ambulatory blood pressure monitoring in male children receiving stimulant therapy.Annals of Pharmacotherapy, 36, 1142-1149.
Sverd, J., Gadow, K. D., Nolan, E. E., Sprafkin, J., & Ezor, S. N. (1992). Methylphenidate in hyperactive boys with comorbid tic disorder. Advances in Neurology, 58, 271-281.
Swanson, J. M. (1992). School-based assessments and interventions for ADD students. Irvine, CA: K.C. Publishing.
Swanson, J. M. (1993). Effect of stimulant medication on hyperactive children: A review of reviews. Exceptional Child, 60, 154-162.
Swanson, J. M., Cantwell, D., Lerner, M., McBurnett, K., & Hana, G. (1991). Effects of stimulant medication on learning in children with ADHD. Journal of Learning Disabilities, 24, 219-231.
Swanson, J. M., Gupta, S., Lam, A., Shoulson, I., Lerner, M., Modi, N., et al. (2003). Development of a new once-a-day formulation of methylphenidate for the treatment of Attention-Deficit/Hyperactivity Disorder: Proof-of-concept and proof-of-product studies. Archives of General Psychiatry, 60, 204-211.
Swanson, J. M., Gupta, S., Williams, L., Agler, D., Lerner, M., & Wigal, S. (2002). Efficacy of a new pattern of delivery of methylphenidate in the treatment of ADHD: Effects on activity level in the classroom and on the playground. Journal of the American Academy of Child & Adolescent Psychiatry, 41, 1306-1314.
Swanson, J. M., Kraemer, H. C., Hinshaw, S. P., Arnold, L. E., Conners, C. K., Abikoff, H. B., et al. (2001). Clinical relevance of the primary findings of the MTA: Success rates based on severity of ADHD and ODD symptoms at the end of treatment. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 168-179.
Swanson, J., Lerner, M., & Williams, L. (1995). More frequent diagnosis of attention deficit-hyperactivity disorder. New England Journal of Medicine, 333, 944-944.
Szymanski, L., & King, B. H. (1999). Practice parameters for the assessment and treatment of children, adolescents, and adults with mental retardation and comorbid disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 5-31.
Tannock, R., Ickowicz, A., & Schachar, R. (1995a). Differential effects of MPH on working memory in ADHD children with and without comorbid anxiety. Journal of the American Academy of Child & Adolescent Psychiatry, 34, 886-896.
Tannock, R., Schachar, R., & Logan, G. (1995b). Methylphenidate and cognitive flexibility: Dissociated dose effects in hyperactive children. Journal of Abnormal Child Psychology, 23, 235-266.
Tannock, R., Schachar, R. J., Can, R. P., Chajczyk, D., & Logan, G. (1989). Effects of methylphenidate on inhibitory control in hyperactive children. Journal of Abnormal Child Psychology, 17, 473-491.
Teicher, M. H., Anderson, C. M., Polcari, A., Clod, C. A., Maas, L. C., & Renshaw, P. F. (2000). Functional deficits in basal ganglia of children with Attention-Deficit/Hyperactivity Disorder shown with functional magnetic resonance imaging relaxometry. Nature Medicine, 6, 470-473.
Teicher, M. H., Polcari, A., Anderson, C. M., Andersen, S. L., Lowen, S. B., Navalta, C. P. (2003). Rate dependency revisited: Understanding the effects of methylphenidate in children with Attention Deficit Hyperactivity Disorder. Journal of Child & Adolescent Psychopharmacology, 13, 41-51.
Teitelbaum, F., Martinez, R., Parker, A., Henderson, R., Roe, C., Kolling, B., et al. (2001). 2000 drug trend report. Maryland Heights, MO: Express Scripts.
Thompson, S. J., Leigh, L., Christensen, R., Xiong, X., Kun, L. E., Heideman, R., et al. (2001). Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. Journal of Clinical Oncology, 19, 1802-1808.
Tirosh, E., Sadeh, A., Munvez, R., & LaVie, P. (1993). Effects of methylphenidate on sleep in children with Attention-Deficit Hyperactivity Disorder: An activity monitor study. American Journal of Diseases of Children, 147, 1313-1315.
Torres, C., Korones, D., Palumbo, D., Wissler, K., Vadasz, E., & Cox, C. (1996). Effect of methylphenidate in the postradiation attention and memory deficits in children. Annals of Neurology, 40, 331-332.
Tourette’s Syndrome Study Group. (2002). Treatment of ADHD in children with tics: A randomized controlled trial.Neurology, 58, 527-536.
Turgay, A. (2004). Aggression and disruptive behavior disorders in children and adolescents. Expert Review of Neurotherapeutics, 4, 623-632.
Vaidya, C. J., Austin, G., & Kirkorian, G. (1998). Selective effects of methylphenidate in Attention Deficit Hyperactivity Disorder: A functional magnetic resonance study. Proceeds of the National Academy of Science, 95, 14494-14499.
Van der Meere, J., Gunning, B., & Stemerdink, N. (1999). The effect of methylphenidate and clonidine on response inhibition and state regulation in children with ADHD.Journal of Child Psychology & Psychiatry, 40, 291-298.
Vitiello, B., & Jensen, P. (1997). Medication development and testing in children and adolescents. Archives of General Psychiatry, 54, 871-876.
Vitiello, B., Severe, J. B., Greenhill, L. L., Arnold, L. E., Abikoff, H. B., Bukstein, O. G., et al. (2001). Methylphenidate dosage for children with ADHD over time under controlled conditions: Lessons from the MTA. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 188-196.
Volkow, N. D., Fowler, J. S., Gatley, J. S., Logan, J., Wang, G. J., Ding, Y. S., et al. Dewey (1996). Evaluation of the human brain dopamine system with PET. Journal of Nuclear Medicine, 37, 1242-1256.
Volkow, N. D., Fowler, J. S., Wang, G., Ding, Y., & Gatley, S. J. (2002). Mechanism of action of methylphenidate: insights from PET imaging studies. Journal of Attentional Disorders, 6, 31-43.
Volkow, N. D., Wang, G. J., Fowler, J. S., & Ding, Y. S. (2005). Imaging the effects of methylphenidate on brain dopamine: New model on its therapeutic actions for Attention-Deficit/Hyperactivity Disorder. Biological Psychiatry, 57, 1410-1415.
Waber, D. P., & Mullenix, P. J. (2000). Acute lymphoblastic leukemia. In K. O. Yeates, M. D. Ris, & H. G. Taylor (Eds.), Pediatric neuropsychology (pp. 300-319). New York: Guilford Press.
Walling, V. R., & Pfefferbaum, B. (1990). The use of methylphenidate in a depressed adolescent with AIDS. Journal of Developmental & Behavioral Pediatrics, 11, 195-197.
Weber, K. S., Frankenberger, W., & Heilman, K. (1992). The effects of Ritalin on the academic achievement of children diagnosed with Attention-Deficit Hyperactivity Disorder. Developmental Disabilities Bulletin, 20, 49-68.
Weber, P., & Lutschg, J. (2002). Methylphenidate treatment. Pediatric Neurology, 26, 261-266.
Weiss, M., & Murray, C. (2003). Assessment and management of Attention-Deficit Hyperactivity Disorder in adults. Canadian Medical Association Journal, 168, 715-722.
Wells, K. C., Pelham, W. E., Kotkin, R. A., Hoza, B., Abikoff, H. B., Abramowitz, A., et al. (2000). Psychosocial treatment strategies in the MTA study: Rationale, methods, and critical issues in design and implementation. Journal of Abnormal Child Psychology, 28, 483-505.
Wender, P. H. (1995). ADHD in Adults. New York: Oxford University Press.
Wender, E. H. (2001). Managing stimulant medication for Attention-Deficit/Hyperactivity Disorder. Pediatricians in Review, 22, 183-189.
Whalen, C. K., & Henker, B. (1991). Therapies for hyperactive children: Comparisons, combinations, and compromises. Journal of Consulting & Clinical Psychology, 59, 126-137.
Whalen, C. K., Henker, B., Hinshaw, S. P., & Granger, D. A. (1989). Externalizing behavior disorders, situational generality, and the Type A Behavior Pattern. Child Development, 60, 1453-1462.
Whalen, C., Henker, B., Swanson, J., Granger, D., Kliewer, W., Spencer, J., et al. (1987). Natural social behaviors in hyperactive children: Dose effects of methylphenidate. Journal of Consulting & Clinical Psychology, 55, 187-193.
Wilens, T. E., & Biederman, J. (1992). The stimulants. Psychiatric Clinics of North America, 15, 191-222.
Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003). Does stimulant therapy of Attention-Deficit/Hyperactivity Disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics, 111, 179-185.
Wilens, T. E., & Spencer, T. J. (2000). The stimulants revisited. Child & Adolescent Psychiatry Clinics of North America, 9, 573-603.
Williams, J., Griebel, M. A., & Dykman, R. A. (1998). Neuropsychological patterns in pediatric epilepsy. Seizure, 7, 223-228.
Williams, S. E., Douglas, R. M., Ayyangar, R., Schefft, B. K., & Berch, D. (1998). Recovery in pediatric brain injury: Is psychostimulant medication beneficial? Journal of Head Trauma Rehabilitation, 13, 73-81.
Winsberg, B. G., & Comings, D. E. (1999). Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. Journal of the American Academy of Child & Adolescent Psychiatry, 38, 1474-1477.
Winsberg, B. G., Press, M., Bialer, I., & Kupietz, S. (1974). Dextroamphetamine and methylphenidate in the treatment of hyperactive/aggressive children. Pediatrics, 53, 236-241.
Wolraich, M. L. (2003). The use of psychotropic medications in children: An American view. Journal of Child Psychology & Psychiatry & Allied Disciplines, 44, 159-168.
Wolraich, M. L., & Doffing, M. A. (2004). Pharmacokinetic considerations in the treatment of Attention-Deficit Hyperactivity Disorder with methylphenidate. CNS Drugs, 18, 243-250.
Wolraich, M. L., Greenhill, L. L., Pelham, W., Swanson, J., Wilens, T., Palumbo, D., et al. (2001). Randomized, controlled trial of OROS methylphenidate once a day in children with Attention-Deficit/Hyperactivity Disorder. Pediatrics, 108, 883-892.
Wolraich, M. L., Lindgren, S., Stromquist, A., Milich, R., Davis, C., & Watson, D. (1990). Stimulant medication use by primary care physicians in the treatment of Attention Deficit Hyperactivity Disorder. Pediatrics, 86, 95-101.
Zachor, D. A., Roberts, A. W., Hodgens, J. B., Isaacs, J. S., & Merrick, J. (2006). Effects of long-term psychostimulant medication on growth of children with ADHD. Research in Developmental Disabilities, 27, 162-174.
Zillessen, K. E., Scheuerpflug, P., Fallgatter, A. J., Strik, W. K., & Warnke, A. (2001). Changes of the brain electrical fields during the continuous performance test in Attention-Deficit Hyperactivity Disorder-boys depending on methylphenidate medication. Clinical Neurophysiology, 112, 1166-1173.
Zito, J. M., dosReis, S., Safer, D. J., & Riddle, M. A. (1998). Racial disparity in psychotropic medications prescribed for youths with Medicaid insurance in Maryland. Journal of the American Academy of Child & Adolescent Psychiatry, 37, 179-184.
Zito, J. M., Safer, D. J., DosReis, S., Gardner, J. F., Boles, M., & Lynch, F. (2000). Trends in the prescribing of psychotropic medications to preschoolers. Journal of the American Medical Association, 283, 1025-1030.
Zito, J. M., Safer, D. J., DosReis, S., Gardner, J. F., Magder, L., Soeken, K., et al. (2003). Psychotropic practice patterns for youth: A 10-year perspective. Archives of Pediatric Adolescent & Medicine, 157, 17-25.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Brown, R.T., Daly, B.P. (2009). Neuropsychological Effects of Stimulant Medication on Children’s Learning and Behavior. In: Reynolds, C.R., Fletcher-Janzen, E. (eds) Handbook of Clinical Child Neuropsychology. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-78867-8_22
Download citation
DOI: https://doi.org/10.1007/978-0-387-78867-8_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-70708-2
Online ISBN: 978-0-387-78867-8
eBook Packages: Behavioral ScienceBehavioral Science and Psychology (R0)